Hailai New Creation

海莱新创

Hailai New Creation

Biotech/Healthcare

Hailai Xinchuang is a developer of Tumor Treating Fields (TTF) technology, focused on TTF R&D, production, and clinical research, and is currently the only company in China conducting clinical trials for newly diagnosed GBM (glioblastoma). Hailai Xinchuang's EFE-G100 (indication: GBM) has smoothly…

Latest round: Series C Extension (2021)

Source: ChinaBulls — chinabulls.com

Last updated 2021-11-01